Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety

MLA

Niels G A Willemen, et al. “Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety.” Current Pharmaceutical Design, vol. 28, Jan. 2022, pp. 104–15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b7c1c865c6250c019f315142738df159&authtype=sso&custid=ns315887.

APA

Niels G A Willemen, Eliana B. Souto, Ana Sofia Ramos, Alexandra Abrantes, Margreet Morsink, Lucia Parente, Patrícia Severino, Inês Primo, Elena Sanchez-Lopez, & Fernanda M. Silva. (2022). Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety. Current Pharmaceutical Design, 28, 104–115.

Chicago

Niels G A Willemen, Eliana B. Souto, Ana Sofia Ramos, Alexandra Abrantes, Margreet Morsink, Lucia Parente, Patrícia Severino, Inês Primo, Elena Sanchez-Lopez, and Fernanda M. Silva. 2022. “Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety.” Current Pharmaceutical Design 28 (January): 104–15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b7c1c865c6250c019f315142738df159&authtype=sso&custid=ns315887.